Katherina Aguilera
Doktorand
E-postadress: katherina.aguilera@ki.se
Besöksadress: Entrévägen 2, 18257 Danderyd
Postadress: D1 Kliniska vetenskaper, Danderyds sjukhus, D1 Medicin, 182 88 Stockholm
Om mig
Lab-ansvarig Biomedicinsk analytiker på Kliniskt forskningscentrum Lab, KIDS.
7-month duration of SARS-CoV-2 mucosal immunoglobulin-A responses and- protection. [1]
Marking U, Bladh O, Havervall S, Svensson J, Greilert-Norin N, Aguilera K,
Kihlgren M, Salomonsson AC, Månsson M, Gallini R, Kriegholm C, Bacchus P,
Hober S, Gordon M, Blom K, Smed-Sörensen A, Åberg M, Klingström J, Thålin
C
/Lancet Infect Dis 2023 Feb - 23(2):150-152/
Markers of neutrophil activation and neutrophil extracellular traps in
diagnosing patients with acute venous thromboembolism: A feasibility study
based on two VTE cohorts. [2]
Smith P, Rosell A, Farm M, Bruzelius M, Aguilera Gatica K, Mackman N, Odeberg
J, Thålin C
/PLoS One 2022 - 17(7):e0270865/
Robust humoral and cellular immune responses and low risk for reinfection at
least 8 months following asymptomatic to mild COVID-19. [3]
Havervall S, Ng H, Jernbom Falk A, Greilert-Norin N, Månberg A, Marking U,
Laurén I, Gabrielsson L, Salomonsson AC, Aguilera K, Kihlgren M, Månsson M,
Rosell A, Hellström C, Andersson E, Olofsson J, Skoglund L, Yousef J, Pin E,
Lord M, Åberg M, Hedhammar M, Tegel H, Dönnes P, Phillipson M, Nilsson P,
Klingström J, Mangsbo S, Hober S, Thålin C
/J Intern Med 2022 Jan - 291(1):72-80/
Response by Mackman et al to Letter Regarding Article, "Patients With
COVID-19 Have Elevated Levels of Circulating Extracellular Vesicle Tissue
Factor Activity That Is Associated With Severity and Mortality-Brief Report".
[4]
Mackman N, Hisada Y, Grover SP, Rosell A, Havervall S, von Meijenfeldt F,
Aguilera K, Lisman T, Thålin C
/Arterioscler Thromb Vasc Biol 2021 Jun - 41(6):e381-e382/
Prognostic value of circulating markers of neutrophil activation, neutrophil
extracellular traps, coagulation and fibrinolysis in patients with terminal
cancer. [5]
Rosell A, Aguilera K, Hisada Y, Schmedes C, Mackman N, Wallén H, Lundström
S, Thålin C
/Sci Rep 2021 Mar - 11(1):5074/
Circulating Markers of Neutrophil Extracellular Traps Are of Prognostic Value
in Patients With COVID-19. [6]
Ng H, Havervall S, Rosell A, Aguilera K, Parv K, von Meijenfeldt FA, Lisman
T, Mackman N, Thålin C, Phillipson M
/Arterioscler Thromb Vasc Biol 2021 Feb - 41(2):988-994/
Patients With COVID-19 Have Elevated Levels of Circulating Extracellular
Vesicle Tissue Factor Activity That Is Associated With Severity and
Mortality-Brief Report. [7]
Rosell A, Havervall S, von Meijenfeldt F, Hisada Y, Aguilera K, Grover SP,
Lisman T, Mackman N, Thålin C
/Arterioscler Thromb Vasc Biol 2021 Feb - 41(2):878-882/
SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in
Sweden. [8]
Rudberg AS, Havervall S, Månberg A, Jernbom Falk A, Aguilera K, Ng H,
Gabrielsson L, Salomonsson AC, Hanke L, Murrell B, McInerney G, Olofsson J,
Andersson E, Hellström C, Bayati S, Bergström S, Pin E, Sjöberg R, Tegel
H, Hedhammar M, Phillipson M, Nilsson P, Hober S, Thålin C
/Nat Commun 2020 Oct - 11(1):5064/
Quantification of citrullinated histones: Development of an improved assay to
reliably quantify nucleosomal H3Cit in human plasma. [9]
Thålin C, Aguilera K, Hall NW, Marunde MR, Burg JM, Rosell A, Daleskog M,
Månsson M, Hisada Y, Meiners MJ, Sun ZW, Whelihan MF, Cheek MA, Howard SA,
Saxena-Beem S, Noubouossie DF, Key NS, Sheikh SZ, Keogh MC, Cowles MW,
Lundström S, Mackman N, Wallén H, Johnstone AL
/J Thromb Haemost 2020 Oct - 18(10):2732-2743/
The expression of microvesicles in the blood of patients with Graves' disease
and its relationship to treatment. [10]
Mobarrez F, Abraham-Nordling M, Aguilera-Gatica K, Friberg I, Antovic A,
Pisetsky DS, Jörneskog G, Wallen H
/Clin Endocrinol (Oxf) 2016 May - 84(5):729-35/
[1] https://pubmed.ncbi.nlm.nih.gov/36640796
[2] https://pubmed.ncbi.nlm.nih.gov/35901107
[3] https://pubmed.ncbi.nlm.nih.gov/34459525
[4] https://pubmed.ncbi.nlm.nih.gov/34038165
[5] https://pubmed.ncbi.nlm.nih.gov/33658563
[6] https://pubmed.ncbi.nlm.nih.gov/33267662
[7] https://pubmed.ncbi.nlm.nih.gov/33267656
[8] https://pubmed.ncbi.nlm.nih.gov/33033249
[9] https://pubmed.ncbi.nlm.nih.gov/32654410
[10] https://pubmed.ncbi.nlm.nih.gov/26252432
Artiklar
- Article: FRONTIERS IN IMMUNOLOGY. 2024;15:1346749
- Article: JOURNAL OF INTERNAL MEDICINE. 2022;291(1):72-80
- Journal article: ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY. 2021;41(6):E384
- Journal article: THROMBOSIS RESEARCH. 2021;200:s77
- Journal article: THROMBOSIS RESEARCH. 2021;200:s32
- Journal article: THROMBOSIS RESEARCH. 2021;200:s79-s80
- Article: SCIENTIFIC REPORTS. 2021;11(1):5074
- Article: ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY. 2021;41(2):878-882
- Article: ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY. 2021;41(2):988-994
- Article: NATURE COMMUNICATIONS. 2020;11(1):5064
- Article: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2020;18(10):2732-2743
Alla övriga publikationer
- Letter: THE LANCET REGIONAL HEALTH. EUROPE. 2024;38:100872
- Letter: THE LANCET INFECTIOUS DISEASES. 2024;24(2):e80-e81
- Preprint: BIORXIV. 2023
- Letter: NEW ENGLAND JOURNAL OF MEDICINE. 2023;389(17):1626-1628
- Letter: THE LANCET MICROBE. 2023;4(7):e488
- Letter: THE LANCET INFECTIOUS DISEASES. 2023;23(2):150-152
- Letter: ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY. 2021;41(6):e381-e382
- Conference publication: THROMBOSIS RESEARCH. 2021;200:S79-S80
- Conference publication: THROMBOSIS RESEARCH. 2021;200:S32
- Conference publication: THROMBOSIS RESEARCH. 2021;200:S77
- Preprint: MEDRXIV. 2020
- Preprint: BIORXIV.
Anställningar
- Doktorand, Kliniska vetenskaper, Danderyds sjukhus, Karolinska Institutet, 2024-2027
Examina och utbildning
- Biomedicinsk Analytikerexamen, Karolinska Institutet, 2011